Psychedelic therapy: How non-hallucinogenic, psychedelic-like drugs could treat depression, addiction

Scientists are designing "tripless" drugs that mimic psychedelics like LSD and ketamine to treat mood disorders, depression, and addiction. The implications could be significant.

Related Keywords

Gabon ,Oregon ,United States ,Shanghai ,China ,San Francisco ,California ,Greece ,Sheng Wang ,Anhui ,Australia ,New York ,France ,Greek ,French ,Americans ,Mark Rus ,Matthew Banks ,Alexander Shulgin ,Jean Paul Sartre ,Johns Hopkins ,Richard Nixon ,David Olson ,David Yaden ,Roland Griffiths ,Aldous Huxley ,Robin Carhart Harris ,Humphry Osmond ,University Of California ,Transdisciplinary Center ,Yougov ,Shanghai Institute Of Biochemistry ,Consciousness Research ,New York Times ,University Of Wisconsin ,President Richard Nixon ,Delix Therapeutics ,West African ,Ancient Greek ,Shanghai Institute ,Cell Biology ,Steven Olson ,Psychoactive Substances ,